These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7608314)

  • 1. In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product.
    Hwang SS; Gorsline J; Louie J; Dye D; Guinta D; Hamel L
    J Clin Pharmacol; 1995 Mar; 35(3):259-67. PubMed ID: 7608314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers.
    Pade V; Aluri J; Manning L; Stavchansky S
    Biopharm Drug Dispos; 1995 Jul; 16(5):381-91. PubMed ID: 8527687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.
    Chung M; Vashi V; Puente J; Sweeney M; Meredith P
    Br J Clin Pharmacol; 1999 Nov; 48(5):678-87. PubMed ID: 10594469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate.
    Mojaverian P; Rosen J; Vadino WA; Liebowitz S; Radwanski E
    J Pharm Biomed Anal; 1997 Jan; 15(4):439-45. PubMed ID: 8953486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
    Kosoglou T; Radwanski E; Batra VK; Lim JM; Christopher D; Affrime MB
    Clin Ther; 1997; 19(5):1002-12. PubMed ID: 9385487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food on bioavailability of pseudoephedrine and brompheniramine administered from a gastrointestinal therapeutic system.
    Chao ST; Prather D; Pinson D; Coen P; Pruitt B; Knowles M; Place V
    J Pharm Sci; 1991 May; 80(5):432-5. PubMed ID: 1880721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms.
    Brock MH; Dansereau RJ; Patel VS
    Pharmacotherapy; 1994; 14(4):430-7. PubMed ID: 7524044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability assessment of a new liquid controlled-release pseudoephedrine product.
    Graves DA; Rotenberg KS; Woodworth JR; Amsel LP; Hinsvark ON
    Clin Pharm; 1985; 4(2):199-203. PubMed ID: 3987221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology.
    Wang CC; Tejwani Motwani MR; Roach WJ; Kay JL; Yoo J; Surprenant HL; Monkhouse DC; Pryor TJ
    Drug Dev Ind Pharm; 2006 Mar; 32(3):367-76. PubMed ID: 16556541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a standard meal on the absorption of controlled-release pseudoephedrine capsules.
    Wecker MT; Graves DA; Amsel LP; Hinsvark ON; Rotenberg KS
    J Pharm Sci; 1987 Jan; 76(1):29-31. PubMed ID: 3585719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans.
    Yacobi A; Stoll RG; Chao GC; Carter JE; Baaske DM; Kamath BL; Amann AH; Lai CM
    J Pharm Sci; 1980 Sep; 69(9):1077-81. PubMed ID: 7411413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
    Halsas M; Penttinen T; Veski P; Jürjenson H; Marvola M
    Pharmazie; 2001 Sep; 56(9):718-23. PubMed ID: 11593992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension.
    Graves DA; Wecker MT; Meyer MC; Straughn AB; Amsel LP; Hinsvark ON; Bhargava AK; Rotenberg KS
    Biopharm Drug Dispos; 1988; 9(3):267-72. PubMed ID: 3395668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu.
    Stillings M; Little S; Sykes J
    Curr Med Res Opin; 2003; 19(8):791-9. PubMed ID: 14687451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
    Grzeszczak W
    Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
    Likar MD; Mansour HL; Harwood JW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.